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1. Introduction 
Two different lipase activities salt resistant lipase 
and lipoprotein lipase have been isolated from human 
post-heparin plasma [l-3] . These enzymes require 
different conditions to hydrolyze triglyceride emul- 
sions with maximal activity. Apolipoprotein-C II is 
mandatory for the activity of LPL only. By contrast, 
a high salt concentration (1 M NaCl) affords inhibi- 
tion of LPL and maximal activity of SRL. In spite of 
these functional differences it has recently been 
claimed that the enzymes have identical amino acid 
composition, identical terminal amino acid residues 
and very similar molecular weights. The only distin- 
guishing feature reported is different carbohydrate 
moieties [3] . 
The putative similarity between LPL and SRL 
must be reassessed in view of the findings in the 
present work. It is demonstrated that earlier described 
purification procedure by means of affinity chromatog- 
raphy on heparin-Sepharose [4] , yield enzyme frac- 
tions with a high content of antithrombin. Modified 
procedures are described in which this major con- 
taminant is removed by another affinity chromatog- 
raphy on heparin-Sepharose with low affinity for 
antithrombin [5]. 
Abbreviations: Salt resistant lipase, SRL (also called hepatic 
lipase), Lipoprotein lipase (EC 3.1.1.3). LPL 
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2. Materials and methods 
2.1. Pos t-heparin plasma 
Healthy male students were injected intravenously 
with heparin (AB Vitrum, Stockholm, Sweden; 100 IU/ 
kg body wt). Twenty minutes after injection, 500 ml 
piasma was obtained from each subject by plasma- 
pheresis and then immediately chilled to 4°C. All sub- 
sequent fractionation procedures were carried out at 
the same temperature. 
2.2. Heparin-Sepharose 
Unfractionated heparin was isolated and attached 
to Sepharose CL-BB (Pharmacia Fine Chemicals AB, 
Uppsala, Sweden) as described previously [6,7] . 
Fractionated heparin of low affinity for antithrombin 
[5], a generous gift from Drs I. Bjiirk, M. Hook and 
U. Lindahl, was also linked to Sepharose CLdB by 
the same procedure. 
2.3, Anti-antithrombin-Sepharose 
Human antithrombin [8] was kindly supplied by 
Dr I. Bjork. The antigen (1 mg/ml) was emulsified 
with equal vol. Freund’s complete adjuvant and 
rabbits were injected with 0.1 ml aliquots into one 
lymph node on the backside of each thigh. Booster 
doses using the incomplete adjuvant were given 
twice at two week intervals by the same route. The 
rabbits were bled two weeks after the last injection 
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and IgG antibodies were isolated [9] . The immuno- 
sorbent was prepared by coupling the antibodies to 
cyanogen bromide activated Sepharose 4B [IO] . 
2.4. Protein determinations 
The Lowry method was used [ 1 l] with a bovine 
serum albumin standard. Alternatively, protein con- 
centrations were estimated by measuring absorbance 
at 280 nm. 
2.5. Immunodiffusion 
Double [ 121 and radial [ 131 immunodiffusion were 
both carried out in 1% agarose gel containing 0.04 M 
Verona1 buffer (pH 8.6). The gels were stained by 
amido black. 
2.6. Polyacrylamide gel electrophoresis 
The sodium dodecyl sulphate discontinuous buffer 
system of Neville [ 141 was employed. Staining was 
performed with amido black. 
2 .I. Enzyme assays 
The assay medium of Iverius et al. [ 151 was used. 
Triglyceride emulsions were radioactivly labelled with 
glycerol-tri-[9,10-(n)-3H] oleate (1.3 Ci/mol) triglyceride) 
and used at a concentration of 2.5 mg/ml. Appro- 
priate ionic strength was achieved by varying the 
sodium chloride concentration. 
LPL activity was determined at ionic strength 0.16 
using a 20: 1.2 (w/w) soybean oil--egg lecithin emul- 
sion (Intralipid 20%; generously provided by Vitrum 
AB, Stockholm, Sweden). Human serum (20%, V/V) 
was the activator. 
SRL was assayed at ionic strength 1 .O without any 
serum added. Intralipid was employed for screening 
of chromatograms. A 1: 1 (w/w) trioleate-gumarabic 
emulsion [ 161 was the substrate when the specific 
activity of purified SRL was determined. 
Samples for extraction of fatty acids by the method 
of Belfrage and Vaughan [ 171 were taken in duplicates 
at the beginning and at the end of the 30 min incuba- 
tion period. Aliquots (0.2 ml) were mixed with 5 ml 
Instagel (Packard Instrument AB) and counted in a 
Beckman LS-250 liquid scintillation spectrometer. 
Recoveries of the extraction procedures were obtained 
by means of a [3H]oleic acid standard. Radioactivity 
counts were converted to enzyme activity by using 
the specific radioactivity of the emulsion triglyceride 
fatty acids. 
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3. Results 
3 .l Affinity chromatography on hepark-Sepharose 
Post-heparin plasma (1000 ml) was mixed with 
solid NaCl to a final concentration of 0.4 M [3] and 
then equilibrated with 120 ml heparin-Sepharose 
for 30 min. The gel was washed six times with 200 ml 
0.4 M NaCl-30% (v/v) glycerol-O.01 M sodium phos- 
phate (pH 7.5) and packed into a column (2.5 X 
20 cm). After further washing with 3 bed vol. buffer, 
the column was eluted with a linear salt gradient from 
0.4-l .5 M NaCl. Two peaks of lipase activity, 
representing SRL and LPL were resolved (fig.1). Peak 
fractions were pooled and concentrated by 3.6 M 
ammonium sulphate-0.0 1 M sodium phosphate 
(pH 6.5) as described [7] . Protein precipitates were 
dissolved in 1 ml 50% (v/v) glycerol-O.01 M sodium 
phosphate (pH 7.5) and stored at -20°C [7] . Double 
immunodiffusion (fig.2) showed that both enzyme 
fractions contained antithrombin. It corresponded to 
more than 90% of the total protein content in both 
enzyme fractions as determined by radial immuno- 
diffusion. 
3.2. Affinity chromatography on heparin-Sepharose 
with low affiniv for antithrombin 
Four preparations of SRL obtained as described 
200 100 600 800 
EFFLUENT VOLUME (ml) 
F&l. Affinity chromatography on heparin-Sepharose. The 
column (2.5 X 20 cm) was eluted with a 700 ml linear gradient 
of 0.4-1.5 M NaCl in 30% (v/v) glycerol-O.01 M phosphate 
(pH 7.5) at a flow rate of 1 ml/min. The fractions (5 ml) were 
analysed for salt resistant lipase activity (A - A), lipoprotein 
lipase activity (o - l ), absorbance at 280 nm (o - o) and 
sodium chloride concentration (X - X). 
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Fig.2. Immunodiffusion analysis of antithrombin. The 
peripheral wells contained (a) salt resistant lipase fraction 
(tig.1, first peak; 10 pg), (b) human antithrombin (7 ug), 
(c) lipoprotein lipase fraction (fig.1, second peak; 10 ng) 
and (d) bovine milk lipoprotein lipase (7 ng). The central well 
was loaded with anti-human antithrombin. 
above were pooled and NaCl was added to a final 
concentration of 0.4 M. The sample was applied to a 
heparin-Sepharose column (1.6 X 5 cm) with low 
affinity for antithrombin. After washing with 160 ml 
0.4 M NaCl-30% (v/v) glycerol-O.01 M sodium phos- 
phate (PH 7.5), the enzyme was eluted with the same 
buffer containing 0.8 M sodium chloride (tig3A). 
A similar procedure was used for LPL. However, 
the sodium chloride concentration of the buffer was 
EFFLUENT VOLUME (ml) 
0.5 M for sample application and column washing 
and 1.2 M for elution of the enzyme (fig3B). 
3.3, Adsorption to C,-aluminium hydroxide gel 
This purification step was employed for LPL only 
and carried out as described [7] . The enzyme fraction 
obtained after the second heparin-Sepharose chro- 
matography was adsorbed to 2 ml sedimented gel. 
After washing and elution, the enzyme fraction was 
collected by dialysis against ammonium sulphate, 
dissolved in 1 ml 50% (v/v) glycerol-O.01 M sodium 
phosphate (pH 7.5) and stored at -20°C. 
3.4. Chromatography on anti-antithrombin-Sepharose 
The final purification step for both LPL and SRL 
was removal of trace amounts of antithrombin by 
anti-antithrombin-Sepharose. The samples were 
passed through columns (1.5 X 1.5 cm) of the immuno- 
sorbent in the presence of 0.5 M NaCl-30% (v/v) 
glycerol-O.01 M sodium phosphate (pH 7.5). Active 
fractions were pooled, dialyzed against ammonium 
sulphate and stored at -20°C in the presence of 
glycerol as described above. 
3.5. Properties of purified salt resistant lipase and 
lipoprotein lipase 
The purification procedures of SRL and LPL are 
summarized in tables 1 and 2, respectively. 
The purified SRL was active at ionic strength 1 .O 
and did not require any serum activator for maximum 
activity. In accordance with earlier findings [ 181 Intra- 
EFFLUENT VOLUME (ml) 
-I 12 
Fig.3. Affinity chromatography of (A) the salt resistant lipase fraction and (B) the lipoprotein lipase fraction on heparin-Sepharose 
with low affinity for antithrombin (see Materials and methods). Fractions of 4 ml were analyzed for salt resistant lipase activity 
(A - A), lipoprotein lipase activity (o - l ) and absorbance at 280 nm (o - 0). 
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Table 1 
Purification of salt resistant lipase from post-heparin plasma 
--___- 
Volume Proteina Specific activityb Yield 
(ml) (mg) (pmol./min mg) (%) 
Post-heparin plasma 4000 240 000 0.004 100 
Heparin-Sepharose 800 42.5 2 13 
Ammonium sulphate 
3.6 M (dialysis) - _ _ _ 
Heparin-Sepharose 
with low affinity 
for anti-thrombin 35 0.86 44 4 
Anti-antithrombin- 
Sepharose _ _ _ _ 
Ammonium sulphate 
3.6 M (dialysis) 2.5 0.03 120 0.3-0.4 
aThe Lowry method 
bAssayed with a triglyceride-gum arabic emulsion (see Materials and methods) 
Table 2 
Purification of lipoprotein lipase from post-heparin plasma 
Volume 
(ml) 
Proteina 
(mg) 
Specific activityb Yield 
(fimol/min mg) (%) 
Post-heparin plasma 4000 240 000 0.002-0.003 100 
Heparin-Sepharose 740 150 2 50--60 
Ammonium sulphate 
3.6 M (dialysis) _ - _ _ 
Heparin-Sepharose with 
low affinity for anti- 
thrombin 30 1.2 100-150 20-30 
Cy-aluminium hydroxide gel - - _ - 
Ammonium sulphate 
3.6 M (dialysis) 1 0.09 250 3-5 
Anti-human antithrombin- 
Sepharose _ - - 
Ammonium sulphate 
3.6 M (dialysis) 1.5 0.01 400-450 l-2 
~- 
aThe Lowry method 
bAssayed with a triglyceride-phospholipid emulsion activated by human serum (see 
Materials and methods) 
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lipid as the substrate resulted in low lipolytic activities 
with this enzyme. 
The purified LPL required serum or apolipo- 
protein-C II for maximal activity and was completely 
inhibited at ionic strength 1 .O. Furthermore, activity 
curves, obtained by varying the Intralipid concentra- 
tion in the presence of constant amount of apolipo- 
protein-C II, had a biphasic shape which is similar to 
results obtained with highly purified bovine milk 
LPL [19]. 
Electrophoretic analysis of both enzyme fractions 
showed several components (fig.4). 
A B 
Fig.4. Sodium dodecyl sulphate polyacrylamide gel electro- 
phoresis of SRL (A) (20 ~8) and of LPL (B) (10 ug). 
4. Discussion 
Affinity chromatography on heparin-Sepharose 
has been widely used for the purification of post- 
heparin plasma lipases [ l-3,20,2 1 ] . The present 
work demonstrates that this procedure alone yields 
lipase fractions of which a major constituent is anti- 
thrombin. This finding is not surprising, since anti- 
thrombin also has a high affinity for heparin [5] and 
is present in plasma at a concentration of about 
0.2 mg/ml. 
Recently it has been shown that LPL from bovine 
milk binds to heparin-Sepharose of low affinity to 
antithrombin [S ,221 . 
The present method of removing antithrombin 
results in human plasma lipase fractions of far higher 
specific activities (tables 1 and 2) than described 
earlier [2,20,21]. Yet, neither the SRL nor the LPL 
is pure (fig.4). 
The degree of purity of the SRL is hard to assess, 
since it is not known which component is the enzyme 
protein. However, the specific activity obtained by 
the present procedure (table 1) is more than 5-fold 
higher than the highest specific activity so far 
reported [2] . 
The specific activity of the LPL fraction (table 2) 
is about 70% of that of highly purified LPL from 
bovine milk [7] . Assuming that both the bovine and 
the human have specific activities of a similar order, 
the human LPL may be more than 50% pure. Indeed, 
the major component of the LPL fraction (fig.4) has a 
mobility similar to LPL from bovine milk. 
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